Higher photophobia scores have been observed among individuals with migraine with aura compared with those who have migraine without aura.
Researchers aimed to determine whether patients with cluster headache have more sickness absence and disability pension days compared to matched references.
Distinct pattern of abnormal brain connection on fMRI can assist in the differentiation between a healthy brain and a brain with migraine without aura.
While migraine may have a negative impact on driving performance, few research studies have focused on the effect migraine has on the risk for motor vehicle accidents.
Migraine headache is associated with increased risk for cardiovascular disease and cerebrovascular events, including ischemic stroke.
The over-the-counter (OTC), drug-free medical device, ActiPatch®, has obtained a new 510(k) clearance from the Food and Drug Administration (FDA) for the adjunctive treatment of musculoskeletal pain.
Researchers found an association between the site of dural arteriovenous fistulas and headache characteristics.
Members of the AHS have released an evidence-based guideline that provides recommendations on neuroimaging for migraine.
Deployed US military service members with concussion commonly have comorbid conditions that may influence their clinical course and overall recovery.
Ubrogepant, the newly approved calcitonin gene-related peptide antagonist, can relieve migraine symptoms within 2 hours after initial dose.